Hilary Kenny

Department of Obstetrics and Gynecology, University of Chicago

Affiliated withUniversity of Chicago

Research Area

Biography

Hilary Kenny has not added Biography.
If you are Hilary Kenny and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 20	2015

Other Publications

Article	Year
Ovarian follicle development requires Smad3. Molecular endocrinology (Baltimore, Md.)\| PubMed ID: 15192076	2004
Follicle size class contributes to distinct secretion patterns of inhibin isoforms during the rat estrous cycle. Endocrinology\| PubMed ID: 16195413	2006
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer research\| PubMed ID: 17308108	2007
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. International journal of cancer. Journal international du cancer\| PubMed ID: 17546601	2007
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface. The Journal of biological chemistry\| PubMed ID: 18048360	2008
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. The Journal of clinical investigation\| PubMed ID: 18340378	2008
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer research\| PubMed ID: 18381440	2008
MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell cycle (Georgetown, Tex.)\| PubMed ID: 19221481	2009
Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis. Cancer treatment and research\| PubMed ID: 19763444	2009
{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. The American journal of pathology\| PubMed ID: 19808644	2009
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21149615	2011
The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer. Cancer discovery\| PubMed ID: 22013555	2011
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature medicine\| PubMed ID: 22037646	2011
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy. Molecular cancer therapeutics\| PubMed ID: 24061648	2013
Three-dimensional modeling of ovarian cancer. Advanced drug delivery reviews\| PubMed ID: 25034878	2014
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. The Journal of clinical investigation\| PubMed ID: 25202979	2014
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. Nature communications\| PubMed ID: 25653139	2015
Molecular pathways: trafficking of metabolic resources in the tumor microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25691772	2015